WHO announces important changes to multi drug resistant TB treatment

In its last-issued guidance in October 2016, the WHO had restricted usage to the breakthrough drug owing to concerns around its effect on the heart (cardio-toxicity).

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2MVQCuA
via IFTTT